Position in AMGN
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$5,307,230
+$320,109 QoQ
Shares Held
14,656
+3.4% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.43%
of 13F equity value
Holder Rank
#804
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 45%
Shared 0%
None 55%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Verdence Capital Advisors LLC holds $47,881,370 across 14 Drug Manufacturers - General names. AMGN ranks #5 (11.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
7,223 | $8,663,483 | |
| 2 | JNJ |
Johnson & Johnson
|
31,901 | $8,101,896 | |
| 3 | ABBV |
AbbVie Inc.
|
27,419 | $6,899,717 | |
| 4 | MRK |
Merck & Co., Inc.
|
49,521 | $6,363,448 | |
| 5 | AMGN |
Amgen Inc
This page
|
14,656 | $5,307,230 | |
| 6 | PFE |
Pfizer Inc
|
168,925 | $4,067,714 | |
| 7 | AZN |
Astrazeneca PLC
|
15,469 | $2,933,231 | |
| 8 | SNY |
Sanofi
|
46,110 | $1,967,052 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,307,230 | 14,656 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $4,987,121 | 14,174 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $5,221,249 | 15,952 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $4,719,795 | 16,725 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $4,733,167 | 16,952 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $5,154,906 | 16,546 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $3,919,764 | 15,039 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $4,233,517 | 13,139 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $4,359,302 | 13,952 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $3,515,332 | 12,364 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $3,722,082 | 12,923 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $4,039,731 | 15,031 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $2,606,070 | 11,738 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $2,371,084 | 9,808 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $2,096,917 | 7,984 | Shares | Sole | 2023-01-23 | |
| 2022-09-30 | $2,261,212 | 10,032 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $2,143,473 | 8,810 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $2,392,083 | 9,892 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $1,990,759 | 8,849 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $1,619,967 | 7,618 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,206,562 | 4,950 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $755,635 | 3,037 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $624,922 | 2,718 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,162,782 | 4,575 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $1,655,501 | 7,019 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $1,494,728 | 7,373 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||